6505--Levofloxacin Tablets (VA-26-00010919)

The Department of Veterans Affairs National Acquisition Center is seeking pharmaceutical suppliers to provide Levofloxacin Tablets in three different strengths: 250mg, 500mg, and 750mg. The solicitation requires offerors to meet FDA current Good Manufacturing Practices (cGMP) standards and provide a unique 11-digit NDC number for their product. Contract requirements include a mandatory 0.5% Cost Recovery Fee incorporated into pricing, and proposals must include pricing for the base year and all four one-year option periods. The award will be made to the lowest-price technically acceptable offer that meets all solicitation requirements. The proposal deadline is November 5, 2025, at 2:30 PM EST, with electronic submission required to specified VA contacts.

This solicitation is set aside for small businesses, with a size standard of 1,300 employees. McKesson Corporation serves as the Pharmaceutical Prime Vendor for distribution of awarded products to participating government agencies including the VA, Department of Defense, Indian Health Service, and Bureau of Prisons. The total estimated annual usage across all participating agencies ranges from 3,132 to 18,996 bottles per strength, with the contract structured as a base year plus four one-year option periods. The pharmaceutical products will be distributed nationwide through the VA and DoD Pharmaceutical Prime Vendor Programs to support federal healthcare and correctional facilities. This is a commercial products procurement utilizing the Standard Form 1449, designed to streamline the acquisition process for established pharmaceutical products meeting government specifications.